Biolase, Inc. (BIOL): Price and Financial Metrics

Biolase, Inc. (BIOL): $1.15

0.06 (+5.50%)

POWR Rating

Component Grades








BIOL Price/Volume Stats

Current price $1.15 52-week high $97.50
Prev. close $1.09 52-week low $1.07
Day low $1.07 Volume 150,300
Day high $1.18 Avg. volume 156,917
50-day MA $1.55 Dividend yield N/A
200-day MA $13.61 Market Cap 2.64M

BIOL Stock Price Chart Interactive Chart >


  • BIOL scores best on the Growth dimension, with a Growth rank ahead of 90.97% of US stocks.
  • The strongest trend for BIOL is in Value, which has been heading up over the past 101 days.
  • BIOL ranks lowest in Quality; there it ranks in the 3rd percentile.

BIOL Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for BIOL is 149.77 -- better than 99.83% of US stocks.
  • BIOL's price/sales ratio is 0.05; that's higher than the P/S ratio of just 1.32% of US stocks.
  • The volatility of BIOLASE INC's share price is greater than that of 99.22% US stocks with at least 200 days of trading history.
  • Stocks with similar financial metrics, market capitalization, and price volatility to BIOLASE INC are XERS, VNT, TBLT, SHYF, and OTRK.
  • Visit BIOL's SEC page to see the company's official filings. To visit the company's web site, go to

BIOL Valuation Summary

  • BIOL's price/sales ratio is 0; this is 100% lower than that of the median Healthcare stock.
  • Over the past 243 months, BIOL's price/earnings ratio has gone down 93.6.

Below are key valuation metrics over time for BIOL.

Stock Date P/S P/B P/E EV/EBIT
BIOL 2023-11-03 0 0.3 -0.1 -0.4
BIOL 2023-11-02 0 0.3 -0.1 -0.4
BIOL 2023-11-01 0 0.3 -0.1 -0.4
BIOL 2023-10-31 0 0.3 -0.1 -0.4
BIOL 2023-10-30 0 0.3 -0.1 -0.4
BIOL 2023-10-27 0 0.3 -0.1 -0.4

BIOL Growth Metrics

    Its year over year cash and equivalents growth rate is now at -46.87%.
  • Its 4 year cash and equivalents growth rate is now at -52.36%.
  • Its 2 year price growth rate is now at -64.92%.
Over the past 15 months, BIOL's revenue has gone up $14,510,000.

The table below shows BIOL's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 46.819 -24.283 -24.27
2022-06-30 44.34 -21.335 -19.168
2022-03-31 41.239 -18.232 -14.265
2021-12-31 39.188 -16.71 -16.704
2021-09-30 35.301 -14.954 -17.568
2021-06-30 32.309 -13.464 -31.649

BIOL's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • BIOL has a Quality Grade of D, ranking ahead of 22.41% of graded US stocks.
  • BIOL's asset turnover comes in at 0.622 -- ranking 67th of 186 Medical Equipment stocks.
  • TCMD, XENT, and MSA are the stocks whose asset turnover ratios are most correlated with BIOL.

The table below shows BIOL's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.622 0.330 -0.489
2021-03-31 0.599 0.290 -0.720
2020-12-31 0.673 0.271 -0.847
2020-09-30 0.775 0.368 -0.933
2020-06-30 0.945 0.365 -1.223
2020-03-31 1.103 0.376 -0.989

BIOL Price Target

For more insight on analysts targets of BIOL, see our BIOL price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $2.25 Average Broker Recommendation 1.38 (Strong Buy)

Biolase, Inc. (BIOL) Company Bio

BIOLASE, Inc.,a medical device company, develops, manufactures, and markets laser systems in dentistry and medicine in the United States and internationally. It offers Waterlase dental laser systems for cutting soft and hard tissue; and diode laser systems, which are used in soft tissue, pain therapy, and cosmetic procedures, such as teeth whitening. The company was founded in 1984 and is based in Irvine, California.

BIOL Latest News Stream

Event/Time News Detail
Loading, please wait...

BIOL Latest Social Stream

Loading social stream, please wait...

View Full BIOL Social Stream

Latest BIOL News From Around the Web

Below are the latest news stories about BIOLASE INC that investors may wish to consider to help them evaluate BIOL as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

We're closing out the trading week with a breakdown of the biggest pre-market stock movers worth watching for Friday morning!

William White on InvestorPlace | November 10, 2023


BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the third quarter ended September 30, 2023.

Yahoo | November 9, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Pre-market stock movers are a hot topic on Wednesday and we're starting the morning with a breakdown of the biggest ones.

William White on InvestorPlace | November 8, 2023

Landmark Study Performed by the Independent McGuire Institute Confirms Positive 12 Month Clinical Outcomes for BIOLASE REPAIR® Perio Protocol

BIOLASE, Inc.(NASDAQ: BIOL), the global leader in dental lasers, today announced groundbreaking findings from a 12-month follow-up to a clinical trial performed at The McGuire Institute™. The findings will be published in the November 2023 issue of the Journal of Periodontology. The pioneering study was designed to meet the stringent American Association of Periodontology Best Evidence Consensus (BEC) standards, and is the first-of-its-kind study to compare BIOLASE's REPAIR® Perio protocol to th

Yahoo | November 8, 2023


BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release third quarter 2023 financial and operating results on Thursday, November 9, 2023, after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and corporate developments.

Yahoo | November 7, 2023

Read More 'BIOL' Stories Here

BIOL Price Returns

1-mo -30.30%
3-mo -71.88%
6-mo -85.84%
1-year -98.63%
3-year -99.86%
5-year -99.96%
YTD -98.23%
2022 -93.33%
2021 -6.41%
2020 -24.61%
2019 -44.17%
2018 -53.95%

Continue Researching BIOL

Want to see what other sources are saying about Biolase Inc's financials and stock price? Try the links below:

Biolase Inc (BIOL) Stock Price | Nasdaq
Biolase Inc (BIOL) Stock Quote, History and News - Yahoo Finance
Biolase Inc (BIOL) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!